Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07707505
NA

Intracavernosal Exosomes vs. Rectal Ozone for Post-RARP Erectile Dysfunction

Sponsor: Medipol University

View on ClinicalTrials.gov

Summary

This prospective, randomized, controlled trial aims to evaluate and compare the therapeutic efficacy of intracavernosal urine-derived exosomes and systemic rectal ozone therapy in patients experiencing erectile dysfunction (ED) post-robotic-assisted radical prostatectomy (RARP). Patients will be randomized into two distinct intervention arms. The primary objective is to assess the functional recovery of the erectile tissue via the International Index of Erectile Function (IIEF-5) over a 6-month follow-up period. Secondary endpoints include penile hemodynamic alterations and overall health-related quality of life.

Official title: Intracavernosal Exosomes Versus Rectal Ozone Therapy for Erectile Dysfunction Following Robotic-Assisted Radical Prostatectomy

Key Details

Gender

MALE

Age Range

45 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2026-08-01

Completion Date

2027-04-01

Last Updated

2026-07-16

Healthy Volunteers

No

Interventions

BIOLOGICAL

Urine-Derived Exosomes (USC-Exos)

A single (or protocol-specified sequenced) bilateral intracavernosal injection of a sterile, cell-free urine-derived exosome suspension (e.g., 2 cc) into the corpus cavernosum, performed under clinical setting conditions.

PROCEDURE

Rectal Medical Ozone Insufflation

Administration of a standardized medical ozone and oxygen gas mixture (e.g., 30-40 µg/mL concentration) via rectal insufflation. The treatment will be administered for a predetermined number of sessions (e.g., 10 sessions spanning over 5 weeks) using a certified medical ozone generator.

DRUG

Daily Phosphodiesterase type 5 (PDE5) Inhibitor

Oral administration of a daily low-dose PDE5 inhibitor (e.g., Tadalafil 5 mg once daily) for a continuous duration of 6 months, aligning with standard clinical guidelines for post-operative erectile dysfunction management.

Locations (1)

Başakşehir Çam Sakura City Hospital

Istanbul, Başakşehir, Turkey (Türkiye)